 | SIG:DRUG-DESIGN 2020: Special Interest Group: DRUG-DESIGN Virtual Meeting December 1, 2020 |
| Conference website | https://sig-drugdesign2020.github.io/ |
| Submission link | https://easychair.org/conferences/?conf=sigdrugdesign2020 |
The SIG: IN-SILICO Talks: DRUG-DESIGN comprises an Special Interest Group (SIG) organized by members of the RSG-Brazil, a well-established student network recognized as a member of the International Society of Computational Biology Student Council (ISCB-SC).
The SIG: In-silico Talks: Drug Design is planning to occur full-virtually.
This one-day focused meeting aims to promote scientific endeavor and professional exchange in the computational biology approaches applied to developments of drug-design, pharmacogenomics, genome/exome analysis, and personalized medicine. We seek to open space and foster on the development of new computational methods, partnerships with industries and promote the scientific endeavors and opportunities for bioinformaticians in Brazil. We believe that such subjects are highly interesting areas with broad open opportunities to students, industries and government, to cite a few.
Bioinformatics revolutionized the process of drug designing by playing important roles in every stage of this field, from accelerating and improving the tasks of drug target identification and drug candidate screening/refinement, to facilitating the characterization of side effects and the prediction of drug resistance. In 2020, we celebrate the twenty years of the first draft of the human genome. Its remarkable advancements impacted not only our understanding of underlying genetics bases, but also fueled the development of tailored therapies based on human genetic variation, a procedure that gave rise to pharmacogenomics. This discipline discloses that disease treatment could occur according to the interindividual variation in drug responses and therefore stepping toward the personalized medicine concept.
Abstract Submission Deadline was extended until October 17, 2020
Submission Guidelines
Abstracts must be original, written in ENGLISH and submitted as a PDF file following the guidelines on the template: https://tinyurl.com/y9mawzcp. It also should contain the names of all authors and their respective institutions. The correspondence author name must be underlined. The abstract may not exceed the limit of a page and 300 words.
The authors will have the opportunity of proposing it for oral presentation, although the Scientific Committee will determine whether it will be presented as a talk or a poster.
List of Topics
- Molecular Docking
- Molecular Dynamics
- Protein structure determination (Crystallography, NMR, Cryo-EM)
- Crystallographic fragment screening
- Computer-Aided Drug Design (CADD)
- Omics approaches for target/drug discovery
- Target Prediction and Validation
- Drug-Receptor interactions
- Drug-repurposing
- Virtual Screening
- Pharmacogenomics
- Personalized Medicine
- Network and Systems Biology
- Cheminformatics
- Epigenetics
- Databases and Software Development
Organizing committee
- Liliane Conteville (Fiocruz - RJ)
- Néli Da Fonseca (UFMG/EMBL-EBI)
- Nilson Coimbra (UFMG)
- Dra. Ana Carolina Guimarães (Fiocruz - RJ)
Contact
All questions about submissions should be emailed directly to the conference chairs:
Liliane Conteville (Fiocruz - RJ) - lilianeconteville@gmail.com
Néli Da Fonseca (UFMG/EMBL-EBI) - nelifonseca@ufmg.br
Nilson Coimbra (UFMG) - darn@iscb.org